只用一本书提高英语听力能力!重温经典名著双语阅读小编推荐:跟着纪录片学英语不背单词和语法,轻松学英语
返回列表 回复 发帖

[report整理] SENEWS-2010-03-29

提高英语听力能力 找对方法很重要!

[Homework]SENEWS-2010-03-29

hw

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia.

Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.  Pfizer and GlaxoSmithKline signed the historic advance market commitment agreement last week.  

The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal.  The group says the low cost vaccines could save as many as 7 million lives by the year 2030.

The World Health Organization says pneumonia kills almost 2 million children each year.  This is more than AIDS, malaria and measles combined.  It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world.

These are all reasons why GAVI chose the pneumococcal vaccine for its first advance market commitment project.  The private-public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation.  They provided 1.5 billion dollars to launch the pneumococcal vaccine project.

Jeffrey Rowland is with the GAVI alliance.  He says the money helps to persuade drug makers to take part in the project. The biggest challenge of getting life saving vaccines to poor countries is that there's no market.  People can't afford them. That's why we don't really have a malaria vaccine yet, because no one in rich countries really suffers from malaria.  What we did for the pneumococcal vaccine was we said we will pay 1.5 billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price. And it was a gamble.

That gamble paid off. GlaxoSmithKline and Pfizer have agreed to provide 30 million doses of the vaccine each year for ten years.  The first 20% of the vaccines will sell for 7 dollars a dose.  The remaining 80% will cost 3 dollars and 50 cents per dose.  That is 90% less than current prices in the United States.

Mr. Rowland says the agreement is a huge achievement for the developing world. Vaccination, which we tend to take for granted in countries like the United States or in Western Europe, in fact a lot of us don't even know which diseases we've been vaccinated against.  That's not the case in poor countries.  Vaccination is a life or death question for poor people and if you can vaccinate a child to prevent a disease from happening, it is a lot more cost effective than it is to treat that disease afterwards.

And that's the VOA Special English Development Report.


This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

Mllions of babies and children could soon be protected against the deadly disease Pneumonia.Two leading drug companies have agreed to supply vaccines against * disease to the world's poorest countries at a reduced price.Fighters and * signed the historic advanced market commitment last week.The global alliance for vaccines and immunization or Gabby help negotiate the deal,the group says the low cost vaccines could save as many as 7 million lives by the year 2030.
The World Health Organization says Pneumonia kills almost 2 million children each year,this is more than Eiz,Malaria and Measles combined, it is the leading cause of death among young children.And more than 90% of those deaths happen in the developing world,these are all reasons why Gabby chose the * vaccines for its first advanced market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.Last year, the governments of Italy,The United Kingdom,Canada,Russia and Norway joined with a bill at Molida Gate Foundation.They provided one and half billion dollars to launch the * vaccine project.Jeff Roland is with the Gabby alliance,he says,the money helps to persuade drugmakers to take part in the project.
JEFFThe biggest chanllege to get * vaccine support in poor countries because that is no market,people can not afford them,i am proud that we do not have Malaria vaccine yet because no one in rich countries really suffers Malaria.Well,we did for the pneumo cago vaccine that we said we will pay if 125 dollars you develop the right vaccines and right * that we need at the right price, and it was a gamble.
That gamble paid off. have agreed to provide 30 million doses of the vaccines each year for ten years.The first 20% of the vaccines will sell for 7 dollars a dose,the reminding of 80% will costs 3 dollors and 50 cents per dose.That is 90% less than current prices in the Unites States.Mr.Roland says the agreement is huge achievement for the developing world.
Mr.Rolandvaccination which we tend to take for granted in countries like Unites States or in West Eropean ones. A lots of us do not know which disease we have been vaccined against, en, that is not a case for poor countries,Vaccination is life or death question for poor people,and if you can vaccinate a child to prevent the disease from happening,it is a lot more costly effective than it is to treat that disease after words.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

立即获取| 免费注册领取外教体验课一节

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world’s poorest countries at a reduced price.

Fither and Glaso Smith Cline signed the historic advance market permanent agreement last week. The global alliance for vaccines and immunizations or galley help negotiate the deal.

The group says the low cost vaccines could save as many as seven million lives by the year 2030. The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and missles combined. It is the leading cause of death among young children. And more than 90 percent of those deaths happen in the developing world.

These are all reasons why Galley chose the pneumococcal vaccines for its first advance market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.  

Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation(比尔盖茨夫妇基金会). They provided one and a half billion dollars to large the pneumococcal vaccine project.

Jerffry Rolin is wait the galley alliance. He says the money helps to persuade drug makers to take part in the project.

“The big challenge galley alliance vaccine supports countries additional market people cannot afford them.* we don’t have pneumonia vaccines because no one in earth country suffer from pneumonia. Well we get for the pneumococcal vaccine we said we will pay 125 billion dollars if you develop the right vaccines and *right with me and at right price. And every every example.”

Wide gable paid off. Nockso Smith Clairen and Phiser have agreed to provide thirty million dozes of the vaccine each year for ten years. The first 20 percent of the vaccines will sell for seven dollars a doze. The remaining 80 percent will cost 3 dollars and 50 cents per doze. That is ninety percent less than current prices in the United States.

Mr. Rolin says the agreement is a huge achievement for the developing world.

“that nation which we can in countries that United States or…

And that’s the VOA Special English Development Report written by June Simms. I’m Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

实现无障碍英语沟通

[Homework]SENEWS-2010-03-29

Homework

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at reduced price. Pfizer and Glaxo Simth Kline signed the historic advance market commitment agreement last week.

The global aliance for vaccines and immunizations or gavi help negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030.

The world health organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world. These are all reasons why gavi chose the pneumococcal vaccine for its first advance market commitment project.

The private public partnerships are designing to increase the availibility of low cost vaccines in poor areas. Last year, the government of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill & Melinda Gates Foundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project. Jeffery Rollin is with the GAVI alliance. He says the money helps to persuade drug makers to take part in the project.

The biggest challenge of getting life saving vaccine to poor countries is that no market people can not afford them. I'm afraid we don't really, we don't have malaria vaccines yet. Because  no one in rich countries seemly suffers from malaria. Well, we did for pneumococcal vaccine, was we said we will pay one point five billion dollars if you develop the right vaccines and the right volumes that we need and at right price, and it was a gamble.

That gamble payed off. Glaxo Simth Kline and Pfizer have agreed to provide thirty million doses of the vaccine each year for ten years. The first twenty persent of the vaccines will sell for seven dollars a dose, the remaining 80% will cost 3 dollars and fifty cents for a dose. That is 90% less than current prices in the United States.  Mr. Rowland says the agreement is a huge achievement for the developing world.

Vaccination which we tend to take for granted in countries like the United States or in west Europe, in fact a lot of us don't even know which diseases we've been vaccinated against. That's not the case in poor countries. Vaccination is the life or death question for poor people. And if you can vaccinate a child to prevent the disease from happening, it is a lot more cost effective than it is treat that disease afterwards.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

今天中午挺忙,听得晚了一些。。。。



This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

口译专员推荐—>口译训练软件IPTAM口译通
[Homework]SENEWS-2010-03-29



This is the VOA special English Development Report

Millions of babies and children chould soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines aginst pneumocacle disease to the world's poorest countries and to reduce price.Fizer and Blacksoul Smithclain sign the historic advanced market commitment the agreement last week. The global alliance for vaccines and immunizations or Ganbi help negotiate the deal. The group says the law cost vaccines could save as many as 7million lives by the year 2030.

The World Health Orgnization says pneumonia kills almost 2 million children each year, this is more than Aids, malaria and mizles combined. It is the leading cause of death among young children, and, more than  90% of those death happen in the developing world. These are all reasons why Ganbi choose the pneumocacle vaccine for its first advanced market commitment project.

The private public partnerships are designed to increase the availability of  law cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with a bill and nalendagets foundation. they provided 1.5 billion dollars to launch the pneumocacle vaccine project. Jeffer Rolen is with the Ganbi alliance, he says the money helps to persuade drug makers to take part in the project.

"The biggest chanllenge in geting misle vaccines for the poor countires is there is no market, people can't afford them. and we don't have a malaria vaccines because no one in rich countries really suffers from malaria. Well, we did for the pneumocacle vaccine with we said we will pay 1.5 billion dollars if you dvelop the right vaccines and the right * we need and the right price, and it was a gamble.”

That gamble paid off. Blacksoul Smithclain and Fizer have agreed to provide 30 million doses of the vaccine each year for 10 years. The first 20% of the vaccines will sell for 7 dollars of a dose, the remaining 80% will cost 3 dollars and 50 cent per a dose and that is 90% less than the current prices in the US. Mr Walen says, the agreement is a huge achievement for the developing world.

“Vaccination,which we tend to take for granted in counties like us or west europe, in fact, a lot of us even don;t know which disease we've been vaccinated against. That's not the case in poor coutries. Vaccination is a life or death question for poor people, and if you can vaccinate a child to prevent the disease from happening, it is a lot more cost and effective than it is to treat that desease after words.”

And that' s the VOA Special English Development Report, written by Jun Sens, I am Steve Ember.
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price. Fitzer and Glacso Smith Cline signed the historic advance market commitment agreement last week.

The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.

The world health organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of deaths among young children. And more than ninety percent of those deaths happen in the developing world. These are all reasons why GAVI chose the pneumococcal vaccine for its first advance market commitment project.

The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project.

Jeffry Rolan * with the GAVI alliance. He says the money helps to persuade drug makers to take part in the project.

The biggest challenge of getting lifing vaccines to poor countries is that there is no market. People cannot afford them. As far as we don't really have, we don't have a malaria vaccine yet, because no one in rich countries really suffers from malaria. While we did for the pneumococcal vaccine was recent. We will pay one point five billion dollars if you developed the right vaccines, and the right * that we need, and * the right price. And it was a gamble.

That gamble payed off. Lancsil Smith Cline and Fitzer have a great supervisor thirty million dosis of the vaccine each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents for a dose. That is ninety percent less than current prices in the United States.

Mr. Rolan says the agreement is a huge achievement for the developing world.

Vacctination which we can't take for granted in countries like the United States or in western European *, all on the * that even know the * diseases we have been vaccines against. That's not a case in poor countries. Vaccination is a life or death question for poor people. And if you can vaccinate a child to prevent the disease from happening, it is a lot more cost effective than it is to treat that disease afterwards.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

This is the voa special english development report. Millions of babies and children  could soon be protected against deadly disease pneumonia. Two leading drug companies have agree to supply vaccines against pneumococcal disease to the world's poorest countries at reduced price. Pfizer and B signed the historic advanced market commitment agreement last week.The Global Alliance for vaccines and immunizations or G help negotiate the deal.The group says the low cost vaccines could save as many as 7 million lives by the year 2030.

The World Health Orgnization says pneumonia kills almost two million children each year.This is more than aids, malaria, and measles combined.This is the leading cause of death among young children and more than 90% of those happen in the develping world.These are all reasons why G chose the pneumocaccal vaccine for the its first advance market commitment project. The Private Public Partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the bill and  merlandi gates  foundation.They provided one and a half million dollars to lauch the pneumococcal vaccine project.Jeffery Rollen *   G alliance, he says the money helps to persuade drugs makers to take part in the project.

  The biggest challenge getting massive vaccines in poor countries is there is no market, people can't afford them, I am afraid of really we don't have a malaria vaccines yet, because no one in rich countries ** suffer*. well we did for the pneumococcal vaccine as we said, we will pay one twenty five billion dollars  if you develop the right vaccines and the right volume we need and at right price and it was a gamble. That gamble paid off, G and Pfizer have agree to provide 30 million doses vaccines each year for ten years.The first 20% of the vaccines will sell for 70 dollars a dose, the remain 80% will cost three dollars and fifty cents per dose, that is 90% less than current prices in the United States.

Mr Wallen said the agreement is a huge achievement for the developing world.Vaccinations which we tended to take for granted  in countries like United States or western Europe, a lot of * even know which disease we've been actually against.Hum that's not the case in poor countries vaccines is the life and death question for poor people, and if you can vaccinate a child to provent disease from happening, it is a lot more cost effective than it is to treat that disease afterwards. And that's the voa special english development report written by June Simms.  I'm Steve Ember

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

实现无障碍英语沟通

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia.Two leading drug companies have agreed to supply vaccines against pnuemocorco disease to the world's poorest countries at reduced price. Fizer and Glexal Smith Cline signed the historic advance market commitment agreement last week.

The global alliance for vaccines and immunezations Will Gavvy help negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030.The World Health Organization says pneumonia kills almost two million children each year.This is more than AIDS, malaria and Mizers combined.It is the leading cause of death among young children.And more than 90 percent of those deaths happen in the developing world.These are all reasons why Gavy chose the pneumococa vaccine for its first advance market commitment project.The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.

Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with a bill and Malinda gates foundation.They provided one and a half billion dollars to launch the pneumococa vaccine project.Jeff Roland is with the gavvy Alliance.He says the money helps to persuade drug makers to take part in the project.

The biggest challenge is getting mass of vaccines in poor countries. Because there is no market. People cannot afford them.But we don't have really malaria vaccine yet because no one in rich countries really suffered from malaria.While we did for the pneumococa vaccines, we said we will pay 1.5 billion dollars if you develop the right vaccines in the right volume that we need and at the right price.And it was a gamble.

That gamble paid off.Glaxel Smith Cline and Fizer have agreed to provide 30 millions doses of th vaccine each year for ten years. The first 20% of the vaccines will sell for seven dollars a dose.The remaining 80% will cost three dollars and fifty cents per dose.That is 90% percent less than current prices in the United States.Mr. Rollen says the agreement is a huge achievenment for the developing world.

Daxelation which we tend to take for granted in countries like the United States or in much European... a lot of them still don't even know which diseases will be vaccined against.That is not the case in poor countries. Daxelation is a life or death question for poor people.If you can vaccinate a child to prevent the disease from happening, it is a lot more cost effective than it is to treat that disease afterwards.

And that's the VOA Special English Development written by June Simms. I am Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

普特听力大课堂

[Homework]SENEWS-2010-03-29

This is the VOA special English Development report.

    Millions of babies and children could soon be protected against deadly disease Pneumonia.Two leading drug companies have agreed to supply vaccines against normal carcal disease to the world's poorest countries and reduce price.

    Fizer and Glakso Smithclaim signed the historical advance market commitment agreement last week.The global allies for Vaccines and immunizations or ganty help negotiated the deal.The groups says the low cost vaccines could save as many as seven million lives by the year 2030.

    The World Health Organization says the  Pneumonia kills almost two million children each year.This is more than AIDS,Malaria and Measales combined.It is the leading cause of death among young children,and more than 90 percent of those death happen in the developing world.This are all reasons why Gavy choose the  pneumoniacoccal vaccine for it's first advance market commitment project.

    The private public partnerships are design to increase the avalibality of low cost vaccines in poor areas.Last year,the governments of Italy,the Unite Kingdom,Canada,Russia and Norway joined with a bill and Melindagates foundation.They provided one and a half billion dollars to launch the pneumoniacoccal vaccine project.

    Jeffer Roylen is with the Gaty allience.He says the money helps to persuade drug makers to take part in the project.

    The biggest challenge is getting vaccines to poor countries there is no market.People can afford them.Have flow down we don't have maralia vaccines yet because no one in rich countries really suffer from maralia.While we did for pneumoniacoccal vaccine was we said we will pay 125 billion dollars if you develop the right vaccines in the right * we need and the right price.And it was the gamble.

    That gamble paid off.G and F have agreed to provide 30 million dosis of the vaccines each year for ten years.The first 20% of vaccines will sale for seven dollars a dosis.The remainly 80% will cost 3 dollars and 15 cents per dosis.That is 90% less than current prices in the Unite States.

    Mr.Roylen says the agreement is a huge achievement for the developing world.

    Vaccinations which we tend to take for for guranted in countries like the United States or in Western Europe .A lot of * even know which disease we've been vaccinated against.That not a case for poor countries,vaccination is a life question for poor people,and if you can vaccinate a child to prevent the disease from happen,it's a lot more cost infective than it is to treat that disease after words.

    And that's the VOA special English Development Report.Written by June Simms,I'm steve Ember.




   




This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

好栏目推荐之美国口语俚语

[Homework]SENEWS-2010-03-29

this is the voa special english development report.millions of babies and children could soon be pretected against the deadly disease nomornia.two leading drug companys have agreed to supply vaccines against numor cacal disease to the world 's poorest countries at reduced price.Fizer and Blacical Smith Cline sign the historic advance market commitment agreement last week.the global alliance for vaccines and immunizations all gave help negociate the deal.the group says the low cost vaccines could save as many as 7 million lives by the year 2030.the world health organization says numornia kills almost 2 million children each year.this is more than aids ,malary and missors combined.it is the leading cause of death among young children.and more than 90 percent of those death happen in the developing world.these are all reasons why Gavy choose the numor cacal vaccine for its first advance market commitment project.the private public partnerships are designed to increase their availability of low cost in poor areas.last year ,the goverments of intal,united kingdom,canada,russia and norway joined with the bill and malinda gates(比尔盖茨夫妇) fundation.they provided one and half billion dollars to lauch the numor cacal vaccine project.Jaffry Roland is with the gavy alliance.     he says the money helps to persuade drugmakers to take part in the project.the biggest challenge getting nice vaccine to poor countries is there is no market.people can not afford them.we do not have malary vaccine yet ,because no one in rich countries still suffer the malary.well we did for the numou cacal vaccine as we said we will pay 1.5 billion dollars.if you developed the right vaccines and right volumes as we need and with right price and it was a gamble.that gamble paid off,Galaxy Smith Cline and Fizer have agreed to provide 30 million dots of vaccine each year for ten years.the first 20 percent of the vaccines will sell for 7 dollars a dots.the remaining 80 percent will cost 3 dollars and 50 cents per dots.that is 90 percent less than current prices in the united states.Mr.Wollen the agreement is the huge achievement for the developing world.  bacsination  which we tend to take for granted in countries like united states or in west european     .a lot of that still even know which disease is with being advanced against.that is not casing poor countries .bacsination is a life or death question for poor people,and if you can vaccinate child to prevent the disease from happening,it is a lot more cost effective than it is to treat the disease afterwards.and that's the voa special english development report written by Jone Sins.I am Steve Ember.
This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

This is VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease N. Two leading drug companies have agreed to supply vaccines against n disease to the world's poorest countries at a reduced price.

F and B signed the historic advance market commitment agreement last week. The global aliance for vaccines and immunization or g help negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030.

The World Health Organization says  n kills almost two million children each year. This is more than AIDS, malaria and m combined. It is the leading cause of death among young children. And more than 90 percent of those deaths happen in the developing world.

These are all reasons why G choose the n vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.

Last year, the governments of Italy, the United Kingdom, Canada, Russia, and Norway joined with the bill  at.. foundation. They provided one and a half billion dollars to launch the n vaccine project. J is with the g aliance. He says the money helps to persuade drug makers to take part in the project.

The biggest challenge getting vaccines for poor countries is there is no market ,people can afford them. We don't have a m vaccine yet, because no one in rich countries really suffer from m. Well, we did for the n vaccine was we said we would pay 1.5 billion dollars if you develop the right vaccines and right volum  we need at the right price. And it was a gamble.

That gamble paid off. L and F have agreed to provide 13 million doses of the vaccine each year for ten years. The first 20 percent of the vaccines will sell seven dollars a dose. The remaining 80 percent will cost 3.50 dollars per dose. That is 90 percent less than current price in the United States.

Mr. W says the agreement is a huge achievement for the developing world.

Vaccination which we tend to take for granted in countries like United States or ...In fact, a lot of us don't even know which disease we have been vaccinated against. That's not the case for poor countries. Vaccination is life or death question for poor people. And if you can vaccinate child to prevent disease from happening, it's a lot more cost effect... treat that disease afterwards.

And that's the VOA Special English Development Report.
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

Hw

This is the voa special english development report.
Millions of babies and children could soon be protected against the deadly disease, NOMONIA.
Two leading companies have agreed to supply backthings against newnococo disease to the world’s poorest countries at redused price.Fizer and Blacksoul Smith Claim signed the historic advance market committment agreement last week.
The global alliens for backthings and immunizations, world gatty help negotiate disease. The group says the low cost backthings could save as many as 7 million lives by the year 2030. the world health organization says nomonia kills almost 2 million children each year. This is more than AIDs, malaria and misszols combined. It’s the leading cause of death among young children and more than 90% of those death happen in the developing world. These are all reasons why gatty chose the newmococo backthing for its first advance market committment project. The private public partnerships are designed to increase the availability of low cost backthings on poor areas.
Last year, the governments of italy, the united kingdom, canada, russia and norway, joined with the bill at berlingdam gate foundation, they provided 1.5 billion dollars to launch the newmococo backthing project.
Jeffery Rolling is with the gatty alliens, he says the money helps to persuade the drug markets to take part in the project.
“the biggest challenge gatty, I think that is in the poor countries, since there is no market, people can’t afford them. And through we don't really, we don't have a namonia backthing there. Because no one in rich countries really suffers from namonia, while we did for the newmococo backthing was we said, we could pay 1.5 billion dollars if you develop the right backthings in the right ***** we need, and provide tries. And it, and it was a gamble.”
That gamble paid off. Blacksoul Smith Claim and Fizer have agreed to provide 30 million dosers of backthing each year for 10 years. The first 20% of the backthings will sell for 7 dollars a dose, remaining 80% will cost 3 dollars and 50 cents per dose. That’s 90% less than current prices in the united states. Mr. Rolling says the agreement is a huge achievement for the developing world.
“backthing nations which we can’t take for granted. In countries like united states or in much **** be exacted, a lot of still don't know which disease we been backthing against. Am…that’s not the case in poor countries, backthing nations is life for death, and question for poor people. And if you can backthing the child to prevent the disease from happening, it’s a lot more cost effective than it’s to treat that disease afterwards.”
And that’s the voa special english development reprot. Writtern by June simms, I’m steve ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

每天半小时 轻松提高英语口语

[Homework]SENEWS-2010-03-29

development report.Millions of babies and children could soon be protected against the deadly disease pneumonia.Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world poorest countries at reduced price.
**Signed the historical advance market commitment agreement last week.The global alliance for vaccines and immunizations or help negotiate the deal.The group says the low cost vaccines could save as many as 7 million lives by the year 2030.The world health organization says pneumonia kills almost 2 million children every year.This is more than AIDS,malaria,measles combined.It is the leading cause of death among young children.And more than 70 percent of those death happen in developing world.These are all reasons why gavin chose the pneumonia vaccines for its first advance commitment market project.The private public partherships are designed to increase the availabity of low-cost vaccines in poor areas.Last year the government of Italy,the united kingdom,
canada,russia,norway joined with the Bill and Melinda gates foundation.They provide one and a half billion to launch the pneumococcal vaccine project.
Jeffery Rowland is with the gavi alliance.He says the money help to persuade drugmakers to take part in the project.
The biggest challenge to get life saving vaccine in poor countries is that no market,people can't afford them.That is why we don't really have.We don't have a malaria vaccine yet.Because no one in rich countries really suffers from malaria.While we did for the pneumococcal vaccine was we said we will pay 1.5 billions dollars if you develop the right vaccines and the right volumes we need at a right price. And it was a gamble.
That gamble paid off.**agree to provide 30 million doses of vaccine each year for ten years.The first 20 percent of vaccines were sell for 7 dollars a dose.The remaining 80 percent will cost 3.5 dollars per dose.That is the 90 percent less than the current price in united states.Mr rowland says the agreement is a huge achievement for the developing world.
vaccination which we tend to take for granted in countries like united states or in west European in fact a lot of us even don't know which diseases we have been vaccinated against.That is not a case for poor countries.Vaccination is a life or death question for poor people.And if you can vaccinate the child to provent the disease from happening a lot more coughed effective than it is to treat that disease afterwards.
written by June Simms.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29
This is the VOA Special English Development Report..

[1] Millions of babies and children could soon be protected against the deadly disease *. Two leading drug companies have agreed to supply vaccines against normal c* disease to the world's poorest countries at a reduced price. * and * Smith * signed the historic advance market commitment agreement last week. The global alliance for vaccines and * or * help negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030. The World Health Organization says N* kills almost two million children each year. This is more then AIDS, m* and m* combined. It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world.

[2] These are all reasons why * choose the * * vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia, and Norway, joined with the bill and * foundation. They provided one and a half billion dollars to launch the * vaccine project. * R* diswith the * alliance. He says the money helps to persuade drug makers to take part in the project. "The biggest chance is getting * vaccines to poor countries that is no market. People can afford them. And we don't have M* vaccines yet. Because no one in rich countries really suffer from *. Where we did for the N* vaccine was we said, we will pay 125 billion dollars, if you develop the right vaccines and right volume that we need, at the right price. And it was a gamble."

[3] That gamble paid off. * Smith * and * have agreed to provide 30 million dose of the vaccine each year for ten years. The first twenty percent of the vaccines was sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States. Mr. Rollen says the agreement is a huge achievement for the developing world. "Designation which we tend to take for granted, in countries like United States, or in west area. A lot of those don't even know which diseases we've been designate against. That's not a case in poor countries. Designation is life or death question for poor people. And if you can vaccinate a child, to prevent this disease from happening, that is a lot more cost effective than it is to treat the disease afterwards."

And that's the VOA Special English Development Report, written by June Simms. I’m Steve Ember.
1

评分次数

  • csufor

口译专员推荐—>口译训练软件IPTAM口译通

[Homework]SENEWS-2010-03-29

This is the VOA Special English development report.Millions of babies and children could soon be protected against the deadly disease * .Two leading drug companies have agreed to supply  * against the normal * disease to the world's poorest countries at reduced price.* and * Smith *  signed the  stomach advanced market commitment agreement last week.The global  alliance *  *  * *   helped the negotiation a deal.The group says the low cost *  can save as many as 7 million lives by the year 2030.The World Health Orgnization says the * kills two million children each year.This is more than AIDS,*, *   combined.It is the leading cause of death the * on children.And more than 90% of those deaths happen in the developing world.These are all the reasons why David chose the * * * *    for its first avanced market commitment project.The private-public partnerships are designed to increase  the *  ability of low cost * in poor countries.Last year,the governments of India,the United Kindom,Canada,Russia and Norway joined * gates...

This post was generated by put listening repetition system,  Check the original dictation thread!
返回列表